S&P 500 Industrials Sector SEC Filings — February 22, 2026

23-02-2026

Lincoln Educational Services Corp filed an 8-K on February 23, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure with no directional performance indicators available.

23-02-2026

Tarsus Pharmaceuticals, Inc. filed an 8-K on February 23, 2026, under Items 2.02 and 9.01, disclosing results of operations and financial condition along with financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are provided in the filing summary. This appears to be a standard earnings-related disclosure with no quantified metrics available.

23-02-2026

Generation Income Properties, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-064001), disclosing under Item 2.01 the completion of an acquisition or disposition of assets. No details on transaction parties, structure, value, or financial terms were provided. Sector was not specified.

23-02-2026

DMC Global Inc. filed an 8-K on February 23, 2026 (AccNo: 0000034067-26-000008, Size: 1 MB), disclosing Results of Operations and Financial Condition under Item 2.02 along with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance changes, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with attached exhibits containing further information.

23-02-2026

Coronado Global Resources Inc. filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.

23-02-2026

BioMarin Pharmaceutical Inc filed an 8-K on February 23, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no detailed performance data available.

23-02-2026

Entravision Communications Corp filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-061961), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, timing, or any quantitative metrics are disclosed.

23-02-2026

Barinthus Biotherapeutics plc filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, financial metrics, positive or negative impacts, or quantitative data are provided in the filing summary.

23-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 23, 2026, reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, disclosures, or exhibits are provided, resulting in no quantifiable positive or negative metrics. This multi-item filing appears informational without disclosed financial or operational impacts.

23-02-2026

Illinois Tool Works Inc filed a multi-item 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 1.02 termination of a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. The filing reflects both new commitments and the end of prior ones alongside additional financial obligations. No specific transaction details, values, or impacts are disclosed.

23-02-2026

Kinder Morgan, Inc. filed an 8-K on February 23, 2026, under Item 7.01 Regulation FD Disclosure. No specific core event, financial metrics, transactions, guidance changes, or other quantitative details are disclosed in the provided filing information. This is a voluntary disclosure with no mentioned positive or negative performance indicators.

23-02-2026

Vanda Pharmaceuticals Inc. filed an 8-K on February 23, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the exhibits are provided in the filing summary. No financial metrics, transactions, or quantitative data are mentioned.

23-02-2026

Veris Residential, Inc. filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing announcing financial results with exhibits attached.

23-02-2026

Armata Pharmaceuticals, Inc. filed a Form 8-K on 2026-02-23 (AccNo: 0001104659-26-018333, size: 222 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the disclosed information, transactions, financial metrics, or events provided in the summary. No quantitative data, positive or negative metrics, or period-over-period comparisons are mentioned.

23-02-2026

Resolute Holdings Management, Inc. filed a Form 8-K on February 23, 2026, disclosing under Item 1.01 entry into a new material definitive agreement, under Item 1.02 termination of a prior material definitive agreement, and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No specific details on the nature of the agreements, transaction values, parties involved, or financial terms were provided. This multi-item filing signals significant contractual changes including both a new commitment and termination of an existing one, but lacks quantification of impacts.

23-02-2026

Genprex, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information.

23-02-2026

Candel Therapeutics, Inc. filed an 8-K on February 23, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or events were provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or directional indicators disclosed.

23-02-2026

Getty Images Holdings, Inc. filed an 8-K on February 23, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are provided. This appears to be an informational filing with no quantified financial metrics or directional impacts disclosed.

23-02-2026

GeneDx Holdings Corp. filed an 8-K on February 23, 2026 (AccNo: 0001818331-26-000014), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

23-02-2026

Transcode Therapeutics, Inc. filed an 8-K on February 23, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, or quantitative details are disclosed in the filing summary. This appears to be a voluntary disclosure with attached exhibits, but content details are NOT_DISCLOSED.

23-02-2026

BioNexus Gene Lab Corp filed an 8-K on February 23, 2026 (AccNo: 0001477932-26-000964, Size: 176 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. This is a multi-item informational filing with no quantified metrics or directional impacts provided.

23-02-2026

OptimumBank Holdings, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 8.01 Other Events, which covers material events not specified elsewhere, and Item 9.01 Financial Statements and Exhibits, indicating attachments are included. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantified positive or negative impacts provided.

• ·AccNo: 0001493152-26-007689
• ·File Size: 229 KB

23-02-2026

Ultragenyx Pharmaceutical Inc. filed a Form 8-K on February 23, 2026, under Item 8.01 reporting Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or impacts are disclosed in the provided filing information.

23-02-2026

Blue Foundry Bancorp filed an 8-K on February 23, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

23-02-2026

Fannie Mae filed an 8-K on February 23, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. No positive or negative performance indicators are mentioned.

23-02-2026

Cadence Design Systems Inc filed an 8-K on February 23, 2026 (AccNo: 0000813672-26-000019), disclosing under Item 3.02 unregistered sales of equity securities. No quantitative details such as transaction value, share count, proceeds, recipients, or dates of sales were provided. This is a single-item mandatory filing with no financial metrics, positive or negative, disclosed.

23-02-2026

Sturm Ruger & Co Inc filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

23-02-2026

Dream Finders Homes, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001628280-26-010399), reporting under Item 2.02 Results of Operations and Financial Condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

23-02-2026

Backblaze, Inc. filed a Form 8-K on February 23, 2026 (AccNo: 0001628280-26-010594), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure with attached exhibits.

23-02-2026

Myriad Genetics Inc filed an 8-K on February 23, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the filing summary. Critical financial data including period-over-period comparisons, balance sheet effects, and outlook revisions are NOT_DISCLOSED.

23-02-2026

Diamondback Energy, Inc. filed a Form 8-K on 2026-02-23 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period metrics are disclosed in the provided information. This is a standard earnings-related filing with no extracted quantitative data.

23-02-2026

Teradata Corp filed an 8-K on February 23, 2026, under Item 8.01 Other Events. No specific details on the event, transaction, financial metrics, or other quantitative data are disclosed in the provided filing information.

23-02-2026

Phreesia, Inc. filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer position, appointment or resignation status, reasons, or financial impacts are provided. The event is categorized as an Officer Change with no quantitative metrics or performance comparisons disclosed.

23-02-2026

BED BATH & BEYOND, INC. filed an 8-K on February 23, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information. This represents a standard post-earnings disclosure without detailed performance data.

23-02-2026

Boise Cascade Co filed a Form 8-K on February 23, 2026, under Item 2.02 reporting results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This constitutes a multi-item voluntary disclosure of financial results with no quantitative details available.

23-02-2026

Adeia Inc. filed a Form 8-K on February 23, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified metrics available.

23-02-2026

Genworth Financial Inc filed an 8-K on 2026-02-23 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing related to financial results with no specific revenue, earnings, guidance, or period-over-period metrics provided in the filing description. No positive or negative financial changes are detailed.

23-02-2026

Great Lakes Dredge & Dock Corp filed an 8-K on February 23, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related filing with no detailed performance data available.

23-02-2026

Oric Pharmaceuticals, Inc. filed an 8-K on February 23, 2026 (AccNo: 0001193125-26-063974), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard voluntary disclosure for financial results without quantified metrics available.

23-02-2026

Angel Studios, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement. No specific details regarding the agreement's terms, parties, dollar value, or financial impacts are disclosed in the filing summary. No quantitative metrics, positive or negative changes, or operational effects are mentioned.

23-02-2026

MediaAlpha, Inc. filed a Form 8-K on 2026-02-23 reporting results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics were disclosed in the provided filing information.

23-02-2026

Ingevity Corp filed an 8-K on 2026-02-23 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative impacts are disclosed.

23-02-2026

Erie Indemnity Co filed an 8-K on February 23, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information. This is a multi-item filing likely including earnings exhibits, but details such as guidance or balance sheet impacts are NOT_DISCLOSED.

23-02-2026

Pure Storage, Inc. filed a Form 8-K on February 23, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws, or a change in fiscal year. No specific details regarding the nature of the amendments, effective date, strategic rationale, or any financial impacts are provided in the filing information. This appears to be a single-item informational filing with no quantified metrics or directional implications disclosed.

23-02-2026

Martin Marietta Materials Inc. filed an 8-K on 2026-02-23 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

23-02-2026

TRICO BANCSHARES filed a Form 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transaction details, or scheduled events mentioned.

23-02-2026

Shutterstock, Inc. filed an 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits are disclosed in the provided filing summary.

23-02-2026

STONERIDGE INC filed an 8-K on February 23, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details such as the key position affected, names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or further context provided in the filing summary.

23-02-2026

Alpha Cognition Inc. filed an 8-K on February 23, 2026 (AccNo: 0001213900-26-019355), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any board composition impacts are NOT_DISCLOSED. No quantitative financial metrics, scheduled events, or governance implications are mentioned.

• ·Filing size: 190 KB
• ·Sector: not specified

23-02-2026

Village Farms International, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction size, financial metrics, positive or negative impacts, or other quantitative data are disclosed in the provided filing information. This is a multi-item filing with no period-over-period comparisons or named entities beyond the filer mentioned.

23-02-2026

KRATOS DEFENSE & SECURITY SOLUTIONS, INC. filed an 8-K on 2026-02-23 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet impacts, guidance, or period-over-period comparisons are mentioned. This is a standard earnings-related disclosure with no quantified metrics provided.

23-02-2026

International Battery Metals Ltd. filed a Form 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, accompanied by exhibits under Item 9.01. This multi-item mandatory filing highlights significant corporate actions, where the material agreement represents a potentially strategic development while the unregistered equity sales introduce potential shareholder dilution. No specific transaction values, financial impacts, or other quantitative details are provided.

23-02-2026

EQUITY BANCSHARES INC filed an 8-K on February 23, 2026, under Item 8.01 Other Events. No details on the core event, financial impacts, transactions, or metrics are disclosed in the filing summary provided. This appears to be a single-item voluntary disclosure with no quantitative data or strategic implications specified.

23-02-2026

Twin Vee PowerCats, Co. filed a Form 8-K on February 23, 2026 (AccNo: 0001731122-26-000283), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details provided on the agreement, events, transaction terms, financial impacts, or metrics. No quantitative data, period-over-period comparisons, positive or negative metrics, or scheduled events are disclosed.

23-02-2026

Better Home & Finance Holding Co filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details including transaction value, parties, terms, financial impacts, or strategic context are disclosed.

23-02-2026

Heritage Insurance Holdings, Inc. filed a Form 8-K on 2026-02-23 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantified metrics available.

23-02-2026

Dime Community Bancshares, Inc. /NY/ filed a Form 8-K on February 23, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the events, transactions, or exhibits provided. No quantitative metrics, positive or negative changes, or financial impacts are disclosed.

23-02-2026

Organogenesis Holdings Inc. filed an 8-K on 2026-02-23 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, comparisons, or scheduled events are mentioned.

23-02-2026

Silo Pharma, Inc. filed a Form 8-K on February 23, 2026, reporting unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific transaction details, share counts, dollar values, or financial metrics are disclosed. This multi-item filing signals potential capital raising via dilutive equity issuance, but lacks quantification of impact.

23-02-2026

Verizon Communications Inc filed an 8-K on February 23, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the filing summary provided.

23-02-2026

BARNWELL INDUSTRIES INC filed an 8-K on 2026-02-23 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific financial metrics, revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative data are provided in the filing summary. Sector is not specified.

• ·AccNo: 0001140361-26-006428
• ·Size: 232 KB
• ·Sector: not specified

23-02-2026

Lottery.com Inc. filed an 8-K on 2026-02-23 (AccNo: 0001493152-26-007783) disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. No financial terms, parties involved, deal valuation, strategic rationale, or other quantitative metrics are mentioned. The filing provides limited details on this completed transaction.